Management Team

John Presutti, MBA

CEO and Board Member

In over 30 years in the pharmaceutical business, Mr. Presutti has served as a marketing and business development executive at GD Searle and managed commercial activities for Curatek Pharmaceuticals. Most recently he started and ultimately divested Presutti Laboratories after successfully bringing an antibacterial agent to the US Market. He has successfully taken drugs through the regulatory and commercialization process, both for large pharma and as an independent entrepreneur.

Elijah M. Bolotin, PhD

President, Founder, and Board Member

Dr. Bolotin has over 15 years in pharmaceutical drug development and drug delivery. Prior to PharmaIN, Dr. Bolotin was Group Leader, Drug Delivery, and technical leader for new technology evaluation at Endorex Corp. (IL), and a research scientist at the NYU Medical Center (NY) and the Cardio Center (Moscow). He is the author of numerous scientific publications and patents. Dr. Bolotin received his PhD from Hebrew University, Israel in biochemistry and pharmaceuticals.

Gerry Castillo, PhD

Director of Research and Intellectual Property

Dr. Castillo has over 20 years experience in clinical and analytical biochemistry. Dr. Castillo is author to numerous manuscripts and presentations. Prior to PharmaIN, Dr. Castillo was Director of Biochemistry, Proteotech, Inc. Dr. Castillo is a registered patent agent, and holder of over 40 patents. He received his BS, Biochemistry with honors from University of Saskatchewan, Canada, an MS in Clinical Chemistry from the University of Windsor, and his PhD, in Clinical Biochemistry from the University of Toronto, Canada.